Processa Pharmaceuticals, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Organization and Summary of Significant Accounting Policies (Details Narrative)

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended						9 Months Ended
	Nov. 03, 2025	Aug. 04, 2025	Jun. 18, 2025	Jan. 29, 2025	Oct. 31, 2025	Aug. 31, 2025	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2024
AccountingPoliciesLineItems [Line Items]
Accumulated deficit							$ 97,424,095						$ 97,424,095		$ 87,219,199
Net loss							3,436,573	$ 3,933,918	$ 2,834,405	$ 3,384,703	$ 3,010,326	$ 2,726,381	10,204,896	$ 9,121,410
Net cash used in operating activities													8,484,617	8,997,321
Net proceeds													13,618,718	$ 7,213,721
Cash and cash equivalents							$ 6,308,420						$ 6,308,420		$ 1,191,325
Investor [Member]
AccountingPoliciesLineItems [Line Items]
Shares issued		5,467,181
Gross proceeds		$ 1,200,000
Subsequent Event [Member]
AccountingPoliciesLineItems [Line Items]
Proceeds from exercise of warrants					$ 945,000
Common Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Number of warrants exercised during period													2,912,422
Purchase Agreement [Member]
AccountingPoliciesLineItems [Line Items]
Shares issued			14,310,000	1,030,972
Net proceeds			$ 6,200,000	$ 4,400,000
Purchase Agreement [Member] \| Common Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Warrants to purchase common stock			28,000,000
Number of warrants exercised during period													2,912,422
Purchase Agreement [Member] \| Common Warrants [Member] \| Subsequent Event [Member]
AccountingPoliciesLineItems [Line Items]
Proceeds from exercise of warrants	$ 945,000
Purchase Agreement [Member] \| Series A Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Warrants to purchase common stock				8,050,672
Purchase Agreement [Member] \| Series B Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Warrants to purchase common stock				4,025,336
Purchase Agreement [Member] \| Pre Funded Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Warrants to purchase common stock				7,019,700
Purchase Agreement [Member] \| June PO [Member] \| Pre Funded Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Warrants to purchase common stock			13,690,000
Purchase Agreement [Member] \| Common Warrants [Member]
AccountingPoliciesLineItems [Line Items]
Proceeds from exercise of warrants													$ 728,000
Purchase Agreement [Member] \| Common Warrants [Member] \| Subsequent Event [Member]
AccountingPoliciesLineItems [Line Items]
Number of warrants exercised during period	3,781,267
Securities Purchase Agreement [Member] \| Investor [Member]
AccountingPoliciesLineItems [Line Items]
Shares issued		5,467,181
Gross proceeds		$ 1,200,000
ATM Agreement [Member]
AccountingPoliciesLineItems [Line Items]
Shares issued		4,597,612				4,597,612
Gross proceeds		$ 1,000,000.0				$ 1,000,000.0